SIRT2 Regulates Apoptosis Signaling in Hyperoxic Acute Lung Injury.

Area of Science:

• Pulmonary Medicine
• Molecular Biology
• Cellular Biology

Background:

• High-concentration oxygen therapy can cause hyperoxic acute lung injury (HALI).
• Sirtuin 2 (SIRT2) is implicated in lung injury pathways, including apoptosis and inflammation.
• Understanding SIRT2's role in HALI is crucial for developing new treatments.

Purpose of the Study:

• To investigate the role of Sirtuin 2 (SIRT2) in the pathogenesis of hyperoxic acute lung injury (HALI).
• To explore SIRT2's interaction with FOXO3 and its downstream targets in hyperoxia-induced lung injury.

Main Methods:

• Exposure of wild-type (WT) and SIRT2-deficient (SIRT2-/-) mice to normoxia or hyperoxia for 72 hours.
• Evaluation of hyperoxia-induced responses, including inflammation and apoptosis.
• Assessment of SIRT2 expression in mouse lungs and human infant tracheal aspirates.

Main Results:

• SIRT2 expression increased in WT mice under hyperoxia and in infants with bronchopulmonary dysplasia.
• SIRT2 deficiency significantly attenuated hyperoxia-induced inflammation and apoptosis.
• SIRT2 interacts with FOXO3, affecting its acetylation and downstream gene expression.
• Administration of a SIRT2 inhibitor (AGK2) alleviated HALI in mice.

Conclusions:

• SIRT2 plays a critical role in HALI pathogenesis by regulating apoptotic signaling.
• Targeting SIRT2 presents a potential novel therapeutic strategy for treating hyperoxic acute lung injury.